TABLE 3.
Incidences of stunting, wasting, and underweight from 6 to 84 wk of age in 4 treatment groups
| Zn+MVs1 | Zinc | Multivitamins | Placebo | |
| Stunting | ||||
| Events/child-years, n | 173/460 | 176/478 | 169/470 | 164/459 |
| HR2 (95% CI) | 0.84 (0.67, 1.04) | 0.96 (0.77, 1.18) | 0.93 (0.75, 1.15) | — |
| P | 0.102 | 0.687 | 0.486 | Referent |
| Wasting | ||||
| Events/child-years, n | 89/514 | 118/523 | 110/505 | 99/513 |
| HR3 (95% CI) | 0.92 (0.69, 1.22) | 1.19 (0.91, 1.55) | 1.11 (0.85, 1.46) | — |
| P | 0.546 | 0.203 | 0.458 | Referent |
| Underweight | ||||
| Events/child-years, n | 107/530 | 131/542 | 116/516 | 99/541 |
| HR4 (95% CI) | 0.97 (0.74, 1.27) | 1.23 (0.95, 1.60) | 1.29 (0.99, 1.69) | — |
| P | 0.818 | 0.116 | 0.060 | Referent |
1
Zn+MV, zinc and multivitamin.
2
Adjusted for baseline height-for-age z score.
3
Adjusted for baseline weight-for-height z score
4
Adjusted for baseline weight-for-age z score.